`
`AnthonyJ. Viola
`Andre K. Cizmarik
`Jennifer L. Dereka
`Zachary W. Silverman
`EDWARDS V/ILDMAN PALMER LLP
`Attorneys for Plaintiffs
`Kowa Company, Ltd.,
`Kowa Pharmaceuticals America, Inc., and
`Nissan Chemical Industries, Ltd.
`750 Lexington Ave.
`New York, NY 10022
`(212) 308-4411
`
`UNITED STATES DISTRICT COURT
`SOUTHERN DISTRICT OF NE\ü YORK
`
`Kowa Company, Ltd.,
`Kowa Pharmaceuticals America, Inc., and
`Nissan Chemical Industries, Ltd.,
`
`Plaintiffs,
`
`V.
`
`Amneal Pharmaceuticals, LLC,
`
`Defendant.
`
`Civil Action No.
`
`lY¿v ,21çË
`
`PLAINTIFFS'
`RULE 7.1 CORPORATE
`DISCLOSURE STATEMENT
`
`Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, the undersigned counsel of
`
`record for plaintiffs Kowa Compan¡ Ltd. ("KCL"), Kowa Pharmaceuticals America, Inc.
`
`("KPA"¡ (collectivel¡ "Kowa"), and Nissan Chemical Industries, Ltd. ("NCI") certifies as
`
`follows:
`
`1.
`2.
`
`KPA is a wholly owned U.S. subsidiary of KCL.
`
`As to KCL, there is no parent corporation or publicly held corporation that owns
`
`l0o/o or more of its stock.
`
`
`
`Case 1:14-cv-02758-PAC Document 6 Filed 04/23/14 Page 2 of 2
`
`3.
`
`As to NCI, there is no parent corporation or publicly held corporation that owns
`
`l0o/o or more of its stock.
`
`Dated: New York, New York
`Apnl 17,2014
`
`Kowa Company, Ltd.,
`Kowa Pharmaceuticals America, Inc.,
`and Nissan Chemical Industries, Ltd.
`
`By their attorneys,
`
`Andre K. Cizmarik
`Jennifer L. Dereka
`Zachary W. Silverman
`EDV/ARDS WILDMAN PALMER
`750 Lexington Avenue
`New York, NY 10022
`(2t2) 308-4411
`
`David G. Conlin (to be admitted pro hac více)
`Kathleen B. Carr (to be admitted pro hac více)
`Adam P. Samansky
`EDV/ARDS V/ILDMAN PALMER
`111 Huntington Avenue
`Boston, l[¡4^A02199-7613
`(617) 23e-0100
`
`2
`
`